Equities
Health CareHealth Care Equipment & Services
  • Price (USD)222.96
  • Today's Change-12.71 / -5.39%
  • Shares traded2.59m
  • 1 Year change-21.22%
  • Beta0.8379
Data delayed at least 15 minutes, as of Mar 27 2020 22:30 BST.
More ▼

Profile data is unavailable for this security.

About the company

Anthem, Inc. is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products. It also provides an array of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs and other administrative services. It provides an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits and radiology benefit management.

  • Revenue in USD (TTM)104.26bn
  • Net income in USD4.81bn
  • Incorporated2001
  • Employees70.60k
  • Location
    Anthem Inc220 Virginia AvenueINDIANAPOLIS 46204United StatesUSA
  • Phone+1 (317) 488-6000
  • Fax+1 (317) 488-6260
  • Websitehttps://www.antheminc.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
ANTM:NYQ since
announced
Transaction
value
WellCare Health Plans Inc-Medicaid Plans(2)Announced26 Sep 201926 Sep 2019Announced-8.62%--
Beacon Health Options IncDeal completed06 Jun 201906 Jun 2019Deal completed-19.49%--
Data delayed at least 15 minutes, as of Mar 27 2020 22:30 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
AFLAC Incorporated22.34bn3.30bn25.58bn10.98k8.000.8884--1.144.424.4229.9339.840.1524----2,035,073.002.252.13--------14.7912.88--26.140.181525.942.28-0.372712.462.29--7.57
Anthem Inc104.26bn4.81bn56.26bn70.60k12.091.789.510.539618.4518.45400.54125.451.40----1,476,771.006.454.81--------4.613.62--9.090.387622.4913.167.1229.1513.438.5512.83
Cigna Corp153.74bn5.10bn60.01bn73.70k12.011.336.840.390313.4313.43404.77121.700.9951----2,086,065.003.313.24--------3.334.39--4.910.45190.3882216.5534.4893.8519.4117.290.00
UnitedHealth Group Inc242.16bn13.84bn229.98bn325.00k16.933.9913.560.949714.3214.32250.6160.781.49----745,092.308.737.50--------5.884.86--11.550.395629.317.0313.1715.4619.756.3124.13
Data as of Mar 27 2020. Currency figures normalised to Anthem Inc's reporting currency: US Dollar USD

Institutional shareholders

35.08%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 201919.07m7.56%
BlackRock Fund Advisorsas of 31 Dec 201912.06m4.78%
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Dec 201911.52m4.56%
SSgA Funds Management, Inc.as of 31 Dec 201911.04m4.37%
Wellington Management Co. LLPas of 31 Dec 20198.04m3.19%
Capital Research & Management Co. (International Investors)as of 31 Dec 20196.98m2.77%
Fidelity Management & Research Co. LLCas of 31 Dec 20196.86m2.72%
Invesco Advisers, Inc.as of 31 Dec 20194.81m1.91%
Baillie Gifford & Co.as of 31 Dec 20194.14m1.64%
TCI Fund Management Ltd.as of 31 Dec 20194.00m1.59%
More ▼
Data from 31 Dec 2019 - 31 Dec 2019Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.